Jonathan Lee

Jonathan Lee has worked in the biomedical engineering field since 2010. Jonathan began as an Undergraduate Researcher at KAIST, where they worked on biomedical immunological research in mouse in vivo models. In 2011, they became an intern at the Syracuse Veterans Affairs Medical Center, where they inventoried medical instruments and assisted in routine maintenance of medical devices. In 2012, they were an Undergraduate Researcher Assistant at Rensselaer Polytechnic Institute, where they encapsulated cells in a hydrogel based matrix for cartilage based tissue engineering studies. In 2013, they worked as an Analytical Development and Testing Intern at Bristol-Myers Squibb, where they learned and applied protein purification and analytical techniques. Jonathan also worked as an M.Eng Researcher at Cornell University, where they designed and developed a co-culture enthesis bioreactor for tissue engineered menisci. From 2014 to 2019, Jonathan worked at Cresilon, where they held various roles including Scientist II - Preclinical, Senior Biomedical Engineer, Biomedical Engineer II, and Biomedical Engineer I. Jonathan was responsible for providing primary leadership for preclinical and R&D strategy for stability feasibility studies, high level strategies for release assay design and process development, and ex vivo models for R&D and Preclinical use. Jonathan then worked at Fork & Good, Inc. from 2019 to present, where they held roles as Process Engineer lll/Manager, Process Engineer II, and Research Associate.

Jonathan Lee attended Cornell University from 2013 to 2014, where they obtained a Master of Engineering (M.Eng.) in Biomedical/Medical Engineering. Jonathan then attended Rensselaer Polytechnic Institute from 2009 to 2013, where they obtained a Bachelor of Science (B.S.) in Biomedical/Medical Engineering. In October 2018, Jonathan obtained a certification in Pharmacokinetics and Pharmacodynamics from the BioPharma Institute.